J Hillert Selected Research

J Hillert Research Topics

Disease

46	Multiple Sclerosis 10/2021 - 04/2000
4	Relapsing-Remitting Multiple Sclerosis 01/2016 - 11/2008
4	Necrosis 05/2007 - 03/2000
3	Inflammation (Inflammations) 06/2010 - 11/2002
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2010 - 04/2000
3	Disease Progression 11/2008 - 08/2000
3	Myasthenia Gravis 05/2007 - 03/2000
2	Genetic Predisposition to Disease (Genetic Predisposition) 05/2013 - 03/2004
2	Autoimmune Diseases (Autoimmune Disease) 10/2011 - 06/2008
2	Stroke (Strokes) 11/2009 - 09/2008
2	Alzheimer Disease (Alzheimer's Disease) 04/2002 - 10/2000
1	Pediatric Obesity 03/2015
1	Epstein-Barr Virus Infections 01/2012
1	Infectious Mononucleosis (Glandular Fever) 01/2012
1	Appendicitis 04/2011
1	Arthritis (Polyarthritis) 06/2010
1	Demyelinating Diseases (Demyelinating Disease) 03/2010
1	Neuroinflammatory Diseases 03/2010
1	Rheumatoid Arthritis 03/2010
1	Atherosclerosis 11/2009
1	Vascular Diseases (Vascular Disease) 11/2009
1	Injection Site Reaction 10/2009
1	Sarcoidosis (Schaumann Disease) 11/2008
1	Headache (Headaches) 11/2008
1	Glioblastoma (Glioblastoma Multiforme) 01/2007
1	Carcinogenesis 01/2007
1	Cluster Headache (Cluster Headaches) 11/2002
1	Nervous System Diseases (Neurological Disorders) 12/2001
1	Brain Death (Brain Dead) 10/2000
1	Disease Susceptibility (Diathesis) 08/2000

Drug/Important Bio-Agent (IBA)

5	Interferon-betaIBA 07/2010 - 03/2007
4	Natalizumab (Tysabri)FDA Link 01/2016 - 06/2008
4	HLA Antigens (Human Leukocyte Antigens)IBA 03/2015 - 03/2004
4	AntibodiesIBA 05/2013 - 05/2007
4	Neutralizing AntibodiesIBA 07/2010 - 03/2007
3	HLA-A Antigens (HLA-A)IBA 01/2012 - 03/2004
3	CytokinesIBA 06/2010 - 03/2000
3	Messenger RNA (mRNA)IBA 05/2001 - 03/2000
2	Pharmaceutical PreparationsIBA 01/2016 - 05/2013
2	Myelin-Oligodendrocyte GlycoproteinIBA 06/2010 - 03/2010
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2009 - 08/2000
2	danaparoid (Orgaran)FDA Link 11/2009 - 09/2008
2	LipidsIBA 11/2008 - 04/2002
2	Cholinergic ReceptorsIBA 05/2007 - 03/2000
2	Apolipoproteins E (ApoE)IBA 05/2006 - 04/2002
2	HLA-DR Antigens (HLA-DR)IBA 01/2004 - 10/2001
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2002 - 09/2001
2	CD40 Ligand (CD40L)IBA 04/2002 - 04/2000
2	Proteins (Proteins, Gene)FDA Link 04/2002 - 05/2001
2	HLA-DR15 antigenIBA 03/2002 - 08/2000
2	Interferon-gamma (Interferon, gamma)IBA 06/2001 - 03/2000
1	Vitamin D FDA LinkGeneric 10/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	nitazoxanide (NTZ)FDA Link 01/2016
1	Nicotine FDA Link 07/2013
1	SolventsIBA 05/2013
1	Immunomodulating AgentsIBA 05/2013
1	Nitrous Oxide (Laughing Gas)IBA 05/2013
1	EpitopesIBA 01/2012
1	interleukin-21 (interleukin 21)IBA 10/2011
1	Indicators and Reagents (Reagents)IBA 04/2011
1	Oligoclonal BandsIBA 07/2010
1	pristane (pristan)IBA 06/2010
1	Interleukin-21 ReceptorsIBA 06/2010
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2010
1	CC ChemokinesIBA 03/2010
1	CCR5 Receptors (CCR5 Receptor)IBA 11/2009
1	Glatiramer Acetate (Copaxone)FDA Link 10/2009
1	HLA-DRB1*03:01 antigenIBA 11/2008
1	Immunoglobulin M (IgM)IBA 11/2008
1	ImmunosorbentsIBA 07/2008
1	EnzymesIBA 07/2008
1	Interferon Regulatory FactorsIBA 06/2008
1	Interferon Type IIBA 06/2008
1	AntigensIBA 08/2007
1	Peroxidase (Myeloperoxidase)IBA 07/2007
1	B-Cell Activating FactorIBA 05/2007
1	LigandsIBA 01/2007
1	Tumor Necrosis Factor Ligand Superfamily Member 13IBA 01/2007
1	A-factor (Streptomyces)IBA 01/2007
1	ChemokinesIBA 11/2006
1	4-1BB Ligand (4 1BB Ligand)IBA 10/2006
1	Chemokine ReceptorsIBA 09/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2002
1	ApolipoproteinsIBA 04/2002
1	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 12/2001
1	Leukocyte Common Antigens (CD45 Antigen)IBA 09/2001
1	InterferonsIBA 06/2001
1	Interleukin-18 (Interleukin 18)IBA 01/2001
1	24-hydroxycholesterolIBA 10/2000
1	Genetic Markers (Genetic Marker)IBA 08/2000
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2000
1	AutoantibodiesIBA 03/2000
1	Interleukin-4 (Interleukin 4)IBA 03/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2000
1	Interleukin-10 (Interleukin 10)IBA 03/2000

Therapy/Procedure

2	Therapeutics 03/2010 - 06/2008
1	Aftercare (After-Treatment) 10/2011
1	Appendectomy 04/2011